New Mexico Minority-Based Community Clinical Oncology Program

新墨西哥州少数民族社区临床肿瘤学计划

基本信息

批准号：
7849674
负责人：
MELANIE E ROYCE
金额：
$ 78.3万
依托单位：
UNIVERSITY OF NEW MEXICO
依托单位国家：
美国
项目类别：
财政年份：
2000
资助国家：
美国
起止时间：
2000-08-17 至 2013-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7849674
关键词：
Abbreviations Accountability Adjuvant Agreement American Indians Breast Cancer Center Cancer Control Cancer Therapy Evaluation Program Cancer Trials Support Unit Catchment Area Children&apos s Oncology Group Clinical Protocols Clinical Research Clinical Trials Clinical Trials Network Communities Controlled Clinical Trials Data Division of Cancer Prevention Eastern Cooperative Oncology Group Education and Outreach Evaluation Family Funding Future Goals Grant Growth Health Services Accessibility Hispanic Americans Hispanics Incidence Income Legal Life Malignant Neoplasms Manuscripts Medical Mexican Minority Minority-Based Community Clinical Oncology Program Monitor National Cancer Institute National Surgical Adjuvant Breast and Bowel Project Navajo New Mexico North Central Cancer Treatment Group Operative Surgical Procedures Participant Patients Pattern Pharmaceutical Preparations Physicians Population Prevention Procedures Program Evaluation Progress Reports Protocols documentation Publishing Race Reporting Research Research Ethics Committees Research Infrastructure Review Committee SEER Program Safety Site Societies Southwest Oncology Group Strategic Planning System Therapeutic Therapy Clinical Trials Uninsured Universities Work anticancer research cancer care cancer education cancer health disparity cancer prevention cancer therapy community setting control trial data management ethnic minority population improved informatics shared resource meetings member mortality operation outreach program prevention clinical trial programs rural area socioeconomics treatment center tribal community tumor registry

项目摘要

Description (provided by applicant): With the highest proportion of Hispanics and American Indians of any State (42% Hispanic, and 10% American Indian), New Mexico's 1.9 million people have tremendous cancer health disparities. Ranking only 47th in per capita income, New Mexico's population is relatively young, poor (27%), and uninsured (22%). Nearly 50% live in rural areas with limited access to healthcare. Tracked by The New Mexico Tumor Registry, a founding member of the NCI SEER Program, New Mexico's multiethnic populations has strikingly different patterns of cancer incidence and mortality. While Northern NM Hispanics are derived primarily from early Spanish land grant families, Southern NM Hispanics are more frequently of Mexican descent. The Tribal communities of New Mexico are particularly diverse, with 19 Pueblos, the Navajo Nation and three Navajo Bands, and the Jicarilla and Mescalero Apaches. In this rich context, the goals of The New Mexico Minority-Based Community Clinical Oncology Program (NM MBCCOP) are to build community capacity for clinical research through cancer education and outreach programs, and, to overcome significant socioeconomic and cultural barriers to increase access and accrual to NCI-sponsored cancer treatment and prevention clinical trials. Funded since 2000 (U10CA86780), the NM MBCCOP has worked diligently to build a build a collaborative statewide community clinical trials network (The New Mexico Cancer Care Alliance (NMCCA)) through cooperating legal agreements with shared governance, a single IRB, and integrated operations. The 102 physician participants (61 types A and 41 type B) cover the entire State. The primary regulatory and data management functions of the NM MBCCOP and the NMCCA are located at The University of New Mexico Cancer Center (UNMCC) with 8 other component and 2 affiliate community sites. The NMCCA is primarily responsible for implementing and managing the NM MBCCOP in community settings. In the past funding period, the NM MBCCOP surpassed its accrual goals, averaging 85.7 annual therapeutic and 65.34 annual prevention/control accrual credits. Therapeutic trial accruals have increased 25%. In the last funding period, 521 patients were accrued to NM MBCCOP trials, 319 (61.2%) of whom were ethnic minorities (180 Hispanic, 36 American Indian, and 103 mixed race, other minority, or undeclared). The NM MBCCOP is now poised to significantly increase overall accrual and to improve its prevention and cancer control clinical trial menu in order to increase accrual to prevention and control trials. In summary, the NM MBCCOP has a strong, well functioning statewide infrastructure, a successful accrual record, and a strategic plan for future growth.

描述（由申请人提供）：新墨西哥州的西班牙裔和美洲印第安人比例是所有州中最高的（42% 是西班牙裔，10% 是美洲印第安人），新墨西哥州 190 万人口的癌症健康状况存在巨大差异。新墨西哥州的人均收入仅排名第 47 位，人口相对年轻、贫困 (27%) 且没有保险 (22%)。近 50% 的人生活在农村地区，获得医疗保健的机会有限。根据 NCI SEER 计划创始成员新墨西哥州肿瘤登记处的追踪，新墨西哥州的多种族人口的癌症发病率和死亡率模式截然不同。新墨西哥北部西班牙裔主要来自早期的西班牙土地授予家庭，而新墨西哥南部西班牙裔则更常见的是墨西哥血统。新墨西哥州的部落社区尤其多样化，有 19 个普韦布洛人、纳瓦霍部落和三个纳瓦霍族群，以及吉卡里拉和梅斯卡莱罗阿帕奇人。在这种丰富的背景下，新墨西哥州少数民族社区临床肿瘤学计划 (NM MBCCOP) 的目标是通过癌症教育和推广计划来建设社区临床研究能力，并克服重大的社会经济和文化障碍，以增加获取和推广的机会。参加 NCI 赞助的癌症治疗和预防临床试验。自 2000 年 (U10CA86780) 获得资助以来，NM MBCCOP 一直致力于通过具有共同治理、单一 IRB 和综合运营的合作法律协议，建立一个协作性全州社区临床试验网络（新墨西哥州癌症护理联盟 (NMCCA)）。 102 名医生参与者（61 名 A 类和 41 名 B 类）覆盖了整个州。 NM MBCCOP 和 NMCCA 的主要监管和数据管理职能位于新墨西哥大学癌症中心 (UNMCC)，还有 8 个其他组成部分和 2 个附属社区站点。 NMCCA 主要负责在社区环境中实施和管理 NM MBCCOP。在过去的资助期内，NM MBCCOP 超出了其应计目标，平均每年 85.7 个治疗学分和 65.34 个年度预防/控制应计学分。治疗试验应计费用增加了 25%。在上一个资助期内，共有 521 名患者参加了 NM MBCCOP 试验，其中 319 名患者（61.2%）为少数族裔（180 名西班牙裔、36 名美洲印第安人、103 名混血、其他少数族裔或未申报）。 NM MBCCOP 现在准备显着增加总体应计费用，并改进其预防和癌症控制临床试验菜单，以增加预防和控制试验的应计费用。总之，新墨西哥州 MBCCOP 拥有强大、运转良好的全州基础设施、成功的应计记录以及未来增长的战略计划。